Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Income from Continuing Operations of 1041476221.15 for Q2 2026, up 100.45% year-over-year from 519569496.79 in Q2 2025, and up 280.16% quarter-over-quarter from 273954482.12 in Q1 2026.
Koninklijke Philips (PHG) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 1041476221.15 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 100.45% year-over-year to 1041476221.15; the TTM figure through Jun 2026 stood at 3023057062.1 (down 0.92% YoY), while the FY2025 annual figure was 1047639163.23, up 216.71% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 1041476221.15, up from 273954482.12 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1558012093.44 in Q4 2024, with the low at 1732215298.56 in Q3 2022.
- The 5-year median for Income from Continuing Operations is 146756524.81 (2025), against an average of 109171970.75.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 890.27% in 2022, then jumped 355.16% in 2025.
- Koninklijke Philips' Income from Continuing Operations stood at 129571415.39 in 2022, then sank by 646.39% to 707968460.11 in 2023, then jumped by 320.07% to 1558012093.44 in 2024, then sank by 59.73% to 627419454.42 in 2025, then surged by 65.99% to 1041476221.15 in 2026.
- Business Quant data shows PHG's Income from Continuing Operations at 1041476221.15 in Q2 2026, 273954482.12 in Q1 2026, and 627419454.42 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 273.95 Mn |
| Dec 31, 2025 | 627.42 Mn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 519.57 Mn |
| Mar 31, 2025 | 137.80 Mn |
| Dec 31, 2024 | 1.56 Bn |
| Sep 30, 2024 | 835.75 Mn |
| Jun 30, 2024 | 114.15 Mn |
| Mar 31, 2024 | -857.14 Mn |
| Dec 31, 2023 | -707.97 Mn |
| Sep 30, 2023 | 205.74 Mn |
| Jun 30, 2023 | 155.72 Mn |
| Mar 31, 2023 | -743.83 Mn |
| Dec 31, 2022 | 129.57 Mn |
| Sep 30, 2022 | -1.73 Bn |
| Jun 30, 2022 | -352.13 Mn |
| Mar 31, 2022 | -320.99 Mn |
| Dec 31, 2021 | 145.28 Mn |
| Sep 30, 2021 | 304.26 Mn |